Steven Powell

Develops pharmaceutical products for treatment and management of urological disorders

GIM investment strategy focuses primarily on transactions involving business succession, buyouts and the growth of innovative firms. GIM provides their investee firms with access to their regional and international network of entrepreneurs, sector experts and advisors. The Gilde Buy Out Fund invests in mid-market private equity with a geographical focus on buyout transactions in Germany, Switzerland, Austria, France, Belgium and Luxembourg. They define mid-market as firms having an enterprise value between €75 and €600 million. They seek investment opportunities across all sectors in non-core businesses spun off from large multinationals, public-to-private transactions, secondary buyouts and family businesses. The Gilde Benelux fund targets only management buyouts of mid-market firms headquartered in the Benelux with transactions typically ranging between €15 and €75 million. They seek firms across all sectors with strong or niche market positions, sustainable cash flows, and growth opportunities through buy and build strategies and entrepreneurial management teams. The Gilde Healthcare fund focuses on private start-up firms in the healthcare sector. They seek primarily European and some US firms that develop new therapeutics, diagnostics and medical devices. They are active investment partners with involvement at board level. Portfolio risk is diversified across different development stages, varying business models, markets and geographies. Their preferred exit route is through IPOs within a realistic time-frame.

Develops and manufactures blood gas instruments and support devices

Develops, manufactures, and markets separation technology used for filtration, purification and storage of chemicals, and other liquids and samples

Develops drugs for cancer, neurodegenerative and inflammatory diseases

Researches and develops biopharmaceutical products

Functions as a College/University

Engages in the creation, production and distribution of computer automated cognitive tests

Engages in the discovery and development of therapies for the treatment of cancer and inflammation